Milestone Pharmaceuticals Inc. (NASDAQ: MIST)
$1.65
+0.0600 ( +3.79% ) 181.5K
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Market Data
Open
$1.65
Previous close
$1.59
Volume
181.5K
Market cap
$87.88M
Day range
$1.54 - $1.67
52 week range
$1.12 - $3.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 111 | Mar 21, 2024 |
8-k | 8K-related | 24 | Mar 04, 2024 |
8-k | 8K-related | 16 | Feb 26, 2024 |
8-k | 8K-related | 14 | Dec 26, 2023 |
10-q | Quarterly Reports | 56 | Nov 13, 2023 |
8-k | 8K-related | 47 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |
8-k | 8K-related | 14 | Oct 24, 2023 |
10-q | Quarterly Reports | 54 | Aug 10, 2023 |